Heard on the Street: With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets

With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets.

Health Care Roundup: Market Talk

Find insight on AstraZeneca, Q/C Technologies and more in the latest Market Talks covering the health…

The “Oreo-gate” saga was fake. The parent-group wars over school snacks is very real.

After a fictional saga over Oreos went viral, parents and teachers admitted the reality of snack…

States haven’t yet been able to obtain Covid-19 shots from the CDC, delaying their distribution to millions of children through federal programs, according to people familiar with the matter

The Centers for Disease Control and Prevention hasn’t opened up the ordering process, raising concerns about…

White House chief of staff Susie Wiles said Wednesday that she is cancer free after undergoing treatment for breast cancer earlier this year

The 69-year old was diagnosed with early-stage breast cancer earlier this year.

WHO sees ‘encouraging signs’ in Congo Ebola fight, but warns cases in one eastern region are surging

The World Health Organization reports encouraging signs in the fight against an Ebola outbreak in eastern…

Dr. Nicole Saphier, Trump’s 3rd surgeon general pick, faces Senate grilling

A radiologist who’s a former Fox News contributor will be facing lawmakers as President Donald Trump’s…

A childhood rite moves indoors as kindergartners learn to ride bikes in school gyms

Learning to ride a bike, a classic childhood milestone, is now happening in school gyms and…

Fourth Measles-Related Death Reported in Pennsylvania

The state has recorded nearly 700 cases of the disease since an outbreak started earlier this…

Legend Biotech has tapped a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July

Ingrid Zhang is taking the helm of the cancer therapy company, filling a post vacant since…